The mono-ubiquitination of proliferating cell nuclear antigen (PCNA) by the RAD6-RAD18 complex is involved in the regulation of translesion DNA synthesis, which is one of the sub-pathways of post-replication repair. Translesion DNA polymerases that belong to the Y-family of DNA polymerases have ubiquitin interacting domains, which are required for high a‹nity binding to mono-ubiquitinated PCNA. This suggests an attractive model for mediating polymerase switching in which PCNA is mono-ubiquitinated at the stalled 3? end of the replication fork, and the mono-ubiquitinated PCNA recruits translesion DNA polymerases for bypass replication. However, the fate of the replicative DNA polymerases at the damage site, the regulatory mechanism(s) governing the ubiquitination and the mechanism(s) controlling the switch back to replicative DNA polymerase after translesion DNA synthesis, are still obscure. Biochemical analyses in general, and reconstitution systems with puriˆed proteins, in particular, provide powerful tools for addressing such questions, and have provided insights into the unexpected nature of polymerase switching. The possibility of whether the biochemical events demonstrated in vitro mimic in vivo cellular events in response to DNA damage is discussed.
Introduction
Post-replication repair (PRR) is a damage tolerance mechanism. After UV irradiation, low molecular weight DNA fragments accumulate as a consequence of stalled DNA replication but these gradually convert to high molecular weight products following gap-repair DNA synthesis without removal of the damaged bases. PRR refers to the process of conversion from low molecular weight to high molecular weight DNA, and thus is a mechanism that`tolerates' rather than`repairs' DNA damage (1) .
PRR was found to be defective in cells cultured from patients suŠering from a variant form of the sunlightsensitive hereditary disorder, xeroderma pigmentosum (XP), known as XP variant (XP-V) (2) , although the gene responsible for the disease was not identiˆed for a long time. Twenty-four years after the discovery of the variant form of XP, the groups of Hanaoka and Prakash identiˆed the defective gene product in XP-V patients as a Y-family translesion DNA polymerase, DNA polymerase h (pol h), which has low processivity and extends 3? ends stalled at a cyclobutane thymine dimer by inserting dAMP nucleotides opposite the lesion (3) (4) (5) (6) (7) . Thisˆnding immediately provided a simple explanation for a possible molecular mechanism underlying PRR, and suggested the existence of regulatory mechanisms for the exchange from replicative to translesion DNA polymerases at the damage site for lesionbypass synthesis followed by a reversion to replicative DNA polymerases to restore processive DNA synthesis (4) (5) (6) (7) (8) .
The involvement of protein ubiquitination in PRR has been established from studies of yeast genetics in which PRR-defective mutants, including rad6 and rad18, were isolated. RAD6 and RAD18 encode a ubiquitin conjugating enzyme (E2) and a ubiquitin ligase (E3), respectively, and the two enzymes form a stable complex (9, 10) , with a subunit composition of RAD6-(RAD18) 2 in humans (11) . (Hereafter the human RAD6-RAD18 complex is denoted as`RAD6-(RAD18)2', while the RAD6-RAD18 complex is generally denoted as RAD6-RAD18 complex' because there is no evidence for a ternary complex in other organisms.) The molecular link between the ubiquitin pathway and translesion DNA synthesis was provided when the ubiquitination target protein was identiˆed as the replicative sliding clamp, proliferating cell nuclear antigen (PCNA) (12), Re-assembled elongation complex, which is identical to that shown in A. E) PCNA is released behind the 3? end after dissociation of pol d. F) RFC re-loads PCNA and recruits pol d from solution. G) Re-assembled elongation complex with an increased amount of PCNA on the newly synthesized DNA. H) RFC captures PCNA, which has been sliding back to the 3? end and recruits pol d from solution. I) Re-assembled elongation complex, which is identical to that shown in A and D. J-M) Repetition of steps A-B-E-F-G with elongation of DNA synthesis and an increase in PCNA on the newly synthesized DNA. N-O) Accumulated PCNA on the newly synthesized DNA at the stalled 3? end restricts re-loading of PCNA from solution due to frequent sliding back of PCNA.
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DNA Polymerase Switching between Pol d and Pol h in Vitro followed by the identiˆcation of ubiquitin-binding domains, named ubiquitin-binding zincˆnger (UBZ) and ubiquitin-binding motif (UBM), found in the Y-family polymerases (13) . Indeed, mono-ubiquitinated PCNA has an increasing a‹nity to pol h in a UBZdependent manner, providing an attractive model for a role in polymerase switching (13) (14) (15) (16) Eukaryotic DNA replication can be reconstituted with the puriˆed protein components, pol d, PCNA, replication factor C (RFC) and replication protein A (RPA) using singly primed single-stranded M13 DNA as a template (17) (18) (19) . This system is dependent on pol d but is independent of replicative DNA helicase, and thus seems to be a model system for lagging strand DNA synthesis (20) , suitable for the study of polymerase switching, since the process of PRR is totally dependent on pol d but is independent of DNA polymerase e (pol e), in at least yeast cells (21) .
Mammalian pol d is a distributive polymerase, which becomes processive when bound to the clamp, PCNA (22) (23) (24) (25) (26) . However, even in the presence of PCNA, pol d replicated M13 DNA through a number of dissociating and re-associating steps ( Fig. 1) (27) (28) (29) (30) . The intrinsic property of spontaneous dissociation of mammalian pol d might provide a molecular basis for its e‹cient dissociation at damage sites and at the end of Okazaki fragments. The replication complex consists of pol d, PCNA and RFC (Fig. 1A) (30) . When pol d dissociates from PCNA and the 3? end spontaneously (Fig. 1B) , PCNA is either released behind the growing 3? end (Fig.  1E ) or is captured by RFC remaining at the 3? end ( Fig.  1C) (30) . Next, some of the released PCNA molecules slide back to the 3? end (Fig. 1H ) and are re-captured by RFC (Fig. 1I ), or alternatively, RFC re-loads with unbound PCNA from solution ( Fig. 1F ). In this model, the frequency of re-loading is restricted by the frequency with which PCNA slides back to the 3? end of the DNA, and would thus be determined by the concentration of PCNA on newly synthesized DNA. The maximum stoichiometry of PCNA per stretch of DNA (maximum number of PCNA molecules on a unit length of DNA) is determined by the equilibrium between its free and bound forms. If the amount of bound PCNA reaches the maximum level, re-loading of PCNA from the solution would be prevented by the sliding of PCNA back to the 3? end and its recapture by RFC, which would be much faster than its re-loading from solution. Therefore, at the growing 3? end, PCNA tends to be reloaded from solution due to dilution of bound PCNA during elongation (31) . Consequently, fresh PCNA associates with pol d at the growing 3? end and`used' PCNA accumulates on newly synthesized DNA during the elongation phase of DNA replication ( Fig. 1J-M ) (30) . These dynamic properties of the replication factors suggest that when pol d encounters a DNA lesion, it dissociates rapidly from the 3? end, as in spontaneous dissociation. Indeed, in a model case of stalled replication omitting dCTP, in which DNA synthesis is prevented at the site of the template dGMP, pol d and PCNA behaved just like the elongation complex (31) . Thus, growing and stalled 3?-ends appeared indistinguishable from each other in terms of the biochemical actions of the replication factors. However, at stalled 3? ends, PCNA accumulates to a maximum level on the newly and an increase in mono-ubiquitinated PCNA on the newly synthesized DNA. Events at stalled 3? ends: F) PCNA, associated with the replication complex, is the primary target for mono-ubiquitination with RAD6A-(RAD18) 2 as at growing 3? ends. G) After the dissociation of pol d, mono-ubiquitinated PCNA is released behind the 3? end and unmodiˆed PCNA is re-loaded from solution as for growing 3? ends. H) Pol d and pol h compete for association at the 3? end as same as the case of growing 3? ends (C). I) Pol d re-assembles as a stochastic event into the complex, and then PCNA is again mono-ubiquitinated with RAD6A-(RAD18) 2 . J) Increased PCNA on the newly synthesized DNA restricts re-loading of PCNA from solution. Consequently, mono-ubiquitinated PCNA persists at the 3? end. K) Pol d and pol h compete for association at the 3? end. L) Pol h may assemble into the complex as a stochastic event. The interaction between mono-ubiquitinated PCNA and the UBZ domain of pol h might stimulate this association. M) Translesion DNA synthesis and subsequent DNA replication occur until spontaneous dissociation of pol h. N) Dilution of PCNA on the newly synthesized DNA after restoration of DNA synthesis increases probability of re-loading unmodiˆed PCNA from solution. O) Pol d and pol h compete for association at the 3? end. P) Pol d re-assembles into the complex as a stochastic event and DNA replication continues.
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Yuji Masuda synthesized DNA through repeated dissociation-association cycles of pol d (Fig. 1ABEFGN) . Once PCNA accumulates to a maximum level (Fig. 1N) , reloading of fresh PCNA from solution is restricted since the released PCNA quickly slides back to the 3? end on the newly synthesized DNA before re-loading; in this way the same PCNA molecule persists until DNA replication is restored (Fig. 1GNO) . Therefore, the only diŠerence between growing and stalled 3? ends is the fate of PCNA; fresh PCNA is located at the growing 3? end and`used' PCNA persists at the stalled 3? end (31) .
In
Mono-ubiquitination of PCNA by RAD6-RAD18
PCNA mono-ubiquitination reactions have been reconstituted in yeast and humans (14, 31, 34, 37, 38) . The reaction occurs speciˆcally at the Lys-164 residue and is enhanced strongly when PCNA is loaded onto DNA through the action of RFC. The detailed mechanism underlying the ubiquitination reaction has been analyzed in a human system (31) . Even PCNA on DNA itself is an e‹cient target for RAD6A-(RAD18)2, and RFC further stimulates the reaction, suggesting that the interaction between PCNA and RFC is required for its stimulation. Such stimulation is also observed with pol d. Thus, PCNA placed at the 3? end with pol d and/or RFC can be a primary target for ubiquitination. In a mechanism for stimulation by pol d and RFC, it is suggested that these proteins act to dispose PCNA on the DNA with the correct geometry for catalysis (31) . Indeed, the bclamp of Escherichia coli, the counterpart of PCNA, is tilted on the DNA (39); however, tilted PCNA probably would notˆt the catalytic site of RAD6-RAD18, and furthermore, PCNA mono-ubiquitination occurs simultaneously with DNA replication (31). RAD6A-(RAD18) 2 cannot distinguish PCNA with stalled pol d from PCNA with moving pol d; consequently, the PCNA-mono-ubiquitination reaction is constitutive (31) .
During the elongation of DNA replication, fresh PCNA is loaded at the growing 3? end of nascent DNA strands and`used' PCNA is released behind the 3? end as mentioned above (Fig. 1) (30) . Even though PCNA, interacting with pol d and/or RFC at the 3? end, is ubiquitinated constitutively, once pol d dissociates spontaneously, the ubiquitinated PCNA is released behind the 3? end, and unmodiˆed PCNA is re-loaded from solution ( Fig. 2A-E) . This mechanism maintains the PCNA at the growing 3? end in an unmodiˆed state, restricting association with pol h (Fig. 2CD) , while mono-ubiquitinated PCNA accumulates on the newly synthesized DNA (Fig. 2E) . By contrast ( Fig. 2F-P) , after accumu-lation of PCNA to a maximum level on newly synthesized DNA, ubiquitinated PCNA persists at the stalled 3? end because even when the ubiquitinated PCNA molecule is released behind the 3? end, the same PCNA molecule quickly slides back to the stalled 3? end before re-loading of fresh PCNA can occur (Fig. 2J) . This mechanism keeps PCNA at the stalled 3? end mono-ubiquitinated, stimulating pol h association, while the total amount of mono-ubiquitinated PCNA on the newly synthesized DNA does not increase. Thus, the elongation of newly synthesized DNA increases the total amount of mono-ubiquitinated PCNA, while the inhibition of DNA replication limits the accumulation of mono-ubiquitinated PCNA on the newly synthesized DNA (31) . The same phenomena are also observed in cell-free extracts (40) , suggesting that the mechanism underlying PCNA-ubiquitination is identical in reconstituted and cell-free systems.
Polymerase Switching between Pol d and Pol h
Cell-free systems in humans: Polymerase switching between pol d and pol h in a cell-free system was demonstrated clearly in seminal papers by Hanaoka's group (4, 5) . The authors established a simian virus 40 (SV40) replication reaction using a plasmid with a dened single cyclobutane thymine dimer. Replication was stalled speciˆcally at the cyclobutane thymine dimer in XP-V cell extract but not in HeLa cell extract. Moreover, the stalled replication was restored by the addition of HeLa cell extract or puriˆed pol h (4,5). This report was theˆrst evidence of polymerase switching from pol d to pol h at the damage site followed by switching back to pol d for subsequent replication. Importantly, a truncated pol h, missing the UBZ motif, functioned as well as full-length pol h, suggesting that the UBZ domain of pol h is dispensable for switching in a cell-free system (4, 5) . Other studies demonstrate consistently that neither ubiquitination of PCNA nor RAD18 is required for polymerase switching in a cellfree system (41, 42) . Therefore, it appears that pol h competes simply with other polymerases during the replication of duplex DNA in a cell-free system (7).
Reconstitution system in humans: Polymerase switching has been reconstituted using recombinant human enzymes (31) . In this system, DNA replication with pol d, pol h, PCNA, RFC and RPA, together with the mono-ubiquitination of PCNA via the ubiquitin-activating enzyme E1, RAD6A-(RAD18)2 and ubiquitin are coupled in the same reaction mixture. As demonstrated in cell-free extracts, pol d and pol h switch spontaneously in the reconstitution system with both nondamaged and UV-irradiated templates (31) . When a UV-irradiated template was used, DNA replication with pol d was inhibited strongly and the inhibition was restored by the addition of pol h. Importantly, with higher concentrations of template DNA, PCNA-ubiquitination did not aŠect the switching reaction; however, under lower concentrations of template DNA, the mono-ubiquitination of PCNA clearly stimulated the switch between the two polymerases. The stimulation depended on the UBZ domain of pol h. In the reconstituted system, the lower concentration of the template corresponded to approximately 40 molecules/nucleus in human cells, suggesting that the interaction between UBZ and mono-ubiquitinated PCNA is essential for the e‹cient bypass of one stalled 3?-end in the nucleus (31) .
Reconstitution system in yeast: In the yeast, S. cerevisiae, polymerase switching, which is a much simpler mechanism than in humans, was reconstituted using pol d, pol h, RFC, E. coli single-stranded DNAbinding protein (SSB) and mono-ubiquitinated PCNA or a ubiquitin-PCNA fusion protein (36) . Because DNA replication with yeast pol d is very stable, pol h cannot access the growing 3? end during replication; however, once the replication stalls, pol d dissociates spontaneously allowing pol h to associate with the stalled 3? end. When a ubiquitin-PCNA fusion protein was used, the dissociation of pol d was enhanced and the binding of pol h was stabilized. Surprisingly, the interaction between pol h and the ubiquitin-PCNA fusion protein was very stable, and prevented the re-association of pol d. Thus, removal of the ubiquitin moiety from PCNA seems to be essential for the re-association of pol d in yeast (36) .
Regulation of PCNA-mono-ubiquitination in Vivo
In vitro reactions in cell-free extracts and with recombinant proteins have revealed PCNA-ubiquitination to be constitutive. This is inconsistent with in vivo observations, because mono-ubiquitinated PCNA accumulates in response to treatment with DNA damaging agents (12, 14, 15, (43) (44) (45) . Recently, the ubiquitin protease, USP1, was identiˆed as a deubiquitinase for mono-ubiquitinated PCNA (46) . Interestingly, it was shown that the disruption of USP1 in the avian cell line, DT40, increased the steady-state level of ubiquitinated PCNA. In addition, it was demonstrated that the level of monoubiquitinated PCNA does not further increase following treatment with DNA damaging agents (45), suggesting that mono-ubiquitination of PCNA in DT40 cells is constitutive and that its accumulation is regulated via the deubiquitination by USP1. Similarly, a large increase in mono-ubiquitinated PCNA was also observed in USP1-down regulated human cells (46, 47) and mouse embryonicˆbroblasts from Usp1 knockout mice (48) . In contrast to the data obtained from the avian DT40 system, the mouse and human cells showed further accumulation of mono-ubiquitinated PCNA in response to DNA damaging agents. These results reveal two fractions of mono-ubiquitinated PCNA; one is constitutive and the other is damage inducible in mammalian cells.
Damage-independent, mono-ubiquitinated PCNA is deubiquitinated by USP1 under normal growth conditions and increases following the inactivation of USP1 under UV treatment (46) . This damage-independent PCNA-ubiquitination seems to occur in S phase (44, 49) in response to the constitutive activity of RAD18, since the overexpression of RAD18 itself signiˆcantly induces the mono-ubiquitination of PCNA (43) . These observations are consistent with the in vitro results and conˆrm that PCNA is mono-ubiquitinated constitutively in a replication-dependent manner.
A signiˆcant fraction of the mono-ubiquitinated PCNA accumulates after treatment with DNA damaging agents in a USP1-independent manner in mammalian cells (46) (47) (48) . It is proposed that the RAD6-RAD18 complex is recruited to RPA-coated, singlestranded DNA that persists at stalled replication forks through a direct interaction between RPA and RAD18 (47, 50) , and/or at damage sites via direct interaction with NBS1, which is a component of the MRN (MRE11-RAD50-NBS1) complex (51) . However, there is no direct evidence that RPA-coated, single-stranded DNA and the MRN complex enhance RAD6-RAD18-mediated mono-ubiquitination of PCNA. Rather, it seems that RPA is dispensable for PCNA-ubiquitination in vitro (31, 37) . Alternatively, if the PCNA molecule at the 3? end of nascent DNA strands is also the primary target for ubiquitination in vivo, the accumulation of PCNA might re‰ect an increasing number of 3? ends due to repriming of DNA synthesis (52) and/or activation of replication initiation at adjacent dormant origins, in response to the DNA damage (53) . Further molecular analysis, in an extended reconstitution system with the proteins involved in this process, is required to understand the regulatory mechanisms of PCNA-ubiquitination more fully.
Regulation of Polymerase Switching in Vivo
In vitro reactions in cell-free extracts and with human recombinant proteins revealed that polymerase switching occurs spontaneously in a damage-independent manner, and that mono-ubiquitinated PCNA only stimulates the association of pol h. Do such events occur in vivo? A recent report demonstrated that ubiquitination of PCNA is important, but not essential, for translesion DNA synthesis in mammalian cells (54) . In DT40 cells, the frequent association of pol h with the replication machinery under normal growth conditions is also reported, although it remains to be elucidated whether the association depends on endogenous DNA damage, ubiquitination of PCNA or the UBZ domain of pol h (55). Interestingly, pol h-dependent DNA synthesis itself is harmful to the cell, but is restored by the presence of DNA polymerase z (pol z) suggesting cooperation between pol h and pol z (55). However, the mechanism via which pol z alleviates the harmful eŠects of pol h is currently unknown. Again, further analysis in an extended reconstitution system is needed to understand the molecular mechanisms controlling polymerase switching.
